According to China Drug Distribution Industry Report, 2012-2015 released by Sino Market Insight, the total sales of Chinese drug distribution industry is estimated to surge 102% over 2011 to RMB1.4288 trillion in 2015.
In 2011, the sales of Chinese drug distribution industry totalized RMB942.6 billion, attaining a YoY rise of 23% if excluding non-comparable factors. In 2012, the figure will grow10% YoY to RMB1.0367 trillion. It is expected that the figure will hit RMB1.4288 trillion in 2015, and that Chinese drug retailing industry (including non-medicines) will sustain a CAGR of 11% or so in 2013-2015.
In the forthcoming years, drug distribution in China will characterize the followings :
The industry growth will accelerate in rural market. Among the sales of seven major types of pharmaceuticals in 2011, the sales derived from rural areas climbed 27% over the same period of a year earlier (excluding non-comparable factors) to RMB146.1 billion, with the growth rate rising by roughly 4 percentage points. With the development of rural economy and residents’ concern about their own health, the pharmaceutical sale in rural areas is likely to contribute a larger proportion to the total sales.
The concentration degree of drug retail industry will be further enhanced. Of all the sales of top 100 retail chain companies in 2011, the sales of the top 20 enterprises made up 61%, up 3 percentage points. The drug distribution industry tends to be integrated in the future.
The report covers seven chapters and 118 charts, and highlights the market size and competitive landscape of drug distribution industry in China, market status of wholesale and retail market, as well as financial performance, business development and trends of 10 major drug distribution companies.
SIMILAR MARKET STUDIES
2016 Triethylsilyl trifluoromethanesulfonate Industry Report - Global and Chinese Market Scenario is a professional and in-depth market survey on Global and Chinese Triethylsilyl trifluoromethanesulfonate industry. The report firstly reviews the basic information of Triethylsilyl trifluoromethanesulfonate including its classification, application and manufacturing technology; The report then explores global and China’s top ...
April 2017 | $3000 | View Details >>
Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2016" provides an overview of Vernal Keratoconjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Vernal Keratoconjunctivitis. Report includes an overview of trial numbers and ...
December 2016 | $2500 | View Details >>
The United States Spine Biologics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Spine Biologics industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Spine Biologics market analysis is provided for the ...
June 2016 | $3800 | View Details >>
Notes: Sales, means the sales volume of Nuclear Medicine-Radiopharmaceuticals Revenue, means the sales value of Nuclear Medicine-Radiopharmaceuticals This report studies sales (consumption) of Nuclear Medicine-Radiopharmaceuticals in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for ...
November 2016 | $3900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research